Big pharma, Biotech, Partnering

A biopharma collaboration for big pharma Novartis and Genmab

Posted on 05 June 2012

Tags: , , ,

Novartis, a big pharma company is paying Genmab $2 million up front as part of a biopharma collaboration to develop bispecific antibodies based on the latter’s DuoBody technology against two disease target combinations selected by Novartis.

Under terms of this biopharma deal Genmab will develop panels of bispecific antibodies, and Novartis will be responsible for fully funding all research work.

If all milestones of the biopharma collaboration are met Genmab could earn about $175 million through the partnership, excluding research funding and royalties.

For further deal information visit Current Agreements (subscription required)


Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news- latest deal news for top 50 pharma / big pharma companies

Report: Practical Guide to Finding Partners

Report: Partnering Deals and Alliances with Big Pharma

Report:Partnering Deals and Alliances with Novartis

Report: Bigpharma Partnering Yearbook 2013

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply